| Amyloid blood biomarker detects Alzheimer's disease A Nabers, L Perna, J Lange, U Mons, J Schartner, J Güldenhaupt, ... EMBO molecular medicine 10 (5), e8763, 2018 | 191 | 2018 |
| Amyloid-β-secondary structure distribution in cerebrospinal fluid and blood measured by an immuno-infrared-sensor: A biomarker candidate for Alzheimer’s disease A Nabers, J Ollesch, J Schartner, C Kötting, J Genius, H Hafermann, ... Analytical chemistry 88 (5), 2755-2762, 2016 | 122 | 2016 |
| An infrared sensor analysing label‐free the secondary structure of the Abeta peptide in presence of complex fluids A Nabers, J Ollesch, J Schartner, C Kötting, J Genius, U Haußmann, ... Journal of biophotonics 9 (3), 224-234, 2016 | 75 | 2016 |
| Aβ and tau structure-based biomarkers for a blood-and CSF-based two-step recruitment strategy to identify patients with dementia due to Alzheimer's disease A Nabers, H Hafermann, J Wiltfang, K Gerwert Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 11, 257-263, 2019 | 53 | 2019 |
| Label-free vibrational imaging of different Aβ plaque types in Alzheimer’s disease reveals sequential events in plaque development D Röhr, BDC Boon, M Schuler, K Kremer, JJM Hoozemans, FH Bouwman, ... Acta neuropathologica communications 8 (1), 222, 2020 | 43 | 2020 |
| Prediction of Alzheimer's disease diagnosis within 14 years through Aβ misfolding in blood plasma compared to APOE4 status, and other risk factors H Stocker, A Nabers, L Perna, T Möllers, D Rujescu, A Hartmann, ... Alzheimer's & Dementia, 2019 | 40 | 2019 |
| Amyloid-β misfolding as a plasma biomarker indicates risk for future clinical Alzheimer’s disease in individuals with subjective cognitive decline J Stockmann, IMW Verberk, N Timmesfeld, R Denz, B Budde, ... Alzheimer's Research & Therapy 12, 1-13, 2020 | 39 | 2020 |
| Amyloid‐beta misfolding and GFAP predict risk of clinical Alzheimer's disease diagnosis within 17 years L Beyer, H Stocker, D Rujescu, B Holleczek, J Stockmann, A Nabers, ... Alzheimer's & Dementia 19 (3), 1020-1028, 2023 | 36 | 2023 |
| Reversible Immuno-infrared sensor for the detection of Alzheimer’s disease related biomarkers B Budde, J Schartner, L Tönges, C Kötting, A Nabers, K Gerwert ACS sensors 4 (7), 1851-1856, 2019 | 28 | 2019 |
| Immobilization of proteins in their physiological active state at functionalized thiol monolayers on ATR‐germanium crystals J Schartner, K Gavriljuk, A Nabers, P Weide, M Muhler, K Gerwert, ... ChemBioChem 15 (17), 2529-2534, 2014 | 23 | 2014 |
| TDP‐43 as structure‐based biomarker in amyotrophic lateral sclerosis L Beyer, R Günther, JC Koch, S Klebe, T Hagenacker, P Lingor, ... Annals of Clinical and Translational Neurology 8 (1), 271-277, 2021 | 22 | 2021 |
| The effect of (−)-epigallocatechin-3-gallate on the amyloid-β secondary structure A Acharya, J Stockmann, L Beyer, T Rudack, A Nabers, JC Gumbart, ... Biophysical Journal 119 (2), 349-359, 2020 | 21 | 2020 |
| Chemical functionalization of germanium with dextran brushes for immobilization of proteins revealed by attenuated total reflection fourier transform infrared difference … J Schartner, N Hoeck, J Güldenhaupt, L Mavarani, A Nabers, K Gerwert, ... Analytical chemistry 87 (14), 7467-7475, 2015 | 14 | 2015 |
| Label-free vibrational imaging of different Abeta plaque types in Alzheimer’s disease reveals sequential events in plaque development D Rohr, BDC Boon, M Schuler, K Kremer, JJM Hoozemans, FH Bouwman, ... Acta Neuropathol Commun 8 (1), 222, 2020 | 13 | 2020 |
| An ATR–FTIR sensor unraveling the drug intervention of Methylene Blue, Congo Red, and Berberine on Human Tau and Aβ J Schartner, A Nabers, B Budde, J Lange, N Hoeck, J Wiltfang, C Kötting, ... ACS Medicinal Chemistry Letters 8 (7), 710-714, 2017 | 13 | 2017 |
| Amyloid blood biomarker detects Alzheimer's disease. EMBO Mol Med 10 (5) A Nabers, L Perna, J Lange, U Mons, J Schartner, J Güldenhaupt, ... | 9 | 2018 |
| Amyloid blood biomarker detects Alzheimer’s disease. EMBO Mol Med. 2018; 10 (5): e8763 A Nabers, L Perna, J Lange, U Mons, J Schartner, J Guldenhaupt | 8 | |
| Genetic predisposition, Aβ misfolding in blood plasma, and Alzheimer’s disease H Stocker, A Nabers, L Perna, T Möllers, D Rujescu, AM Hartmann, ... Translational psychiatry 11 (1), 261, 2021 | 6 | 2021 |
| Aβ misfolding in blood plasma is inversely associated with body mass index even in middle adulthood T Möllers, H Stocker, L Perna, A Nabers, D Rujescu, AM Hartmann, ... Alzheimer's research & therapy 13, 1-9, 2021 | 4 | 2021 |
| Correction to: Amyloid-β misfolding as a plasma biomarker indicates risk for future clinical Alzheimer’s disease in individuals with subjective cognitive decline J Stockmann, IMW Verberk, N Timmesfeld, R Denz, B Budde, ... Alzheimer's Research & Therapy 13, 2021 | 4 | 2021 |
